Cervical cancer prevention study in Spain
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at cervical cancer cases in Spain to learn more about how to prevent it. If you were diagnosed with a common type of cervical cancer between 2019 and 2024, your medical information could help improve prevention efforts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman diagnosed with cervical cancer.
- Your cancer must be one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma (the most common types of cervical cancer).
- Your diagnosis must have happened between 2019 and 2024.
- You must have been 18 years or older when you were diagnosed.
- You must not have other rare types of cervical cancer (like neuroendocrine tumors, sarcoma, or lymphoma).
- Your medical records must be complete enough for the study team to review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at HPV infections and women's views about the HPV vaccine in Slovenia. It aims to understand the characteristics of HPV infections and attitudes toward vaccination after the vaccine became available.
This trial tests how well certain programs can increase cervical cancer screening among women in Puerto Rico. If you are overdue for a Pap or HPV test, this study may help you get screened.
This study looks at women in the Stockholm area who tested positive for HPV (a virus linked to cervical cancer) to see if and how often cervical cancer develops. It aims to understand the risk better, which could improve screening and prevention.
This study is testing a new way to organize cervical cancer screening in Portugal using modern tools. It may help make screening more convenient and up-to-date for women who qualify.
This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
Hear when a new Cervical Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.